Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated (VRTX)

Summary

As of today, VRTX price is $496.07, up +2.49% on
VRTX price is currently -7.05% below its historical high of $533.67 set on
VRTX current market cap is $126B, up +30.52% over the past 365 days
VRTX current PE ratio is 28.86
VRTX current annual revenue is $12.07B, up +9.92% year-over-year
The next earnings release for VRTX is on

Profile

Company profile for Vertex Pharmaceuticals Incorporated (VRTX)
MetricValue
Full NameVertex Pharmaceuticals Incorporated
TickerNASDAQ: VRTX
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
Indexes
Websitevrtx.com
Employees6,100

Key Metrics

Vertex Pharmaceuticals Incorporated Key Details
MetricValueDate
Price$496.07
Price, 1D Change+2.49%
Market Cap$126B
-
PE Ratio28.86
Beta0.49
Revenue$12.07B
Revenue, 1Y Change+9.92%
EPS$15.32
EPS, 1Y Change+837.79%

Chart

SUGGESTED SERIES
Vertex Pharmaceuticals Incorporated chart

Events

Vertex Pharmaceuticals Incorporated Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

VRTX Estimates
MetricValueDate
EPS$15.32
EPS Estimate$18.88N/A
EPS Est. Change+23.19%N/A
Revenue$12.07B
Revenue Estimate$13.18BN/A
Revenue Est. Change+9.19%N/A
Current Price$496.07
Price Target$570.00-
Price Tgt. Change+14.90%-

🔒 Log In To Unlock Full Data

EPS

VRTX EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$0.48-$2.08-528.47%
$18.43$15.32-16.88%
$18.88N/A+23.19%
$21.62N/A+41.11%
VRTX EPS reported versus estimate values chart

Revenue

VRTX revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$10.88B$10.98B+0.96%
$11.98B$12.07B+0.77%
$13.18BN/A+9.19%
$14.56BN/A+20.61%
VRTX revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

VRTX Performance
MetricValueDate
Price, 1Y+32.06%
Price, 3Y+43.66%
Market Cap, 1Y+30.52%
Market Cap, 3Y+41.15%
Revenue, 1Y+9.92%
Revenue, 3Y+38.02%
EPS, 1Y+837.79%
EPS, 3Y+19.51%

🔒 Log In To Unlock Full Data

Technicals

VRTX Technical Indicators
MetricValueDate
Current Price$496.07
SMA 200$454.68
SMA 50$473.16
EMA 200$456.90
EMA 50$474.47
MACD$2.13
Beta0.49
ATR$13.82
14-Day RSI59.61
10-Day Volatility23.58%

Dividends

VRTX Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

VRTX Income & Profitability
MetricValueDate
Revenue$12.07B
EPS$15.32
Gross Profit$10.27B
Gross Margin85.03%
Operating Income$4.69B
Operating Margin39.06%
Net Income$3.95B
Net Margin32.94%
EBITDA$4.97B

🔒 Log In To Unlock Full Data

Financial Health

VRTX Financial Health
MetricValueDate
Debt To Equity0.10
Current Ratio2.90
Quick Ratio2.46
-
Piotroski F-Score5
Altman Z-Score12.20

Valuations

VRTX Valuations
MetricValueDate
PE Ratio28.86
PS Ratio9.89
PB Ratio6.21
EV/EBITDA22.85
EV-N/A

Balance Sheet

VRTX Balance Sheet
MetricValueDate
Book Value$18.67B
Cash & Equivalents$6.61B
Total Assets$26.14B
Current Assets$11.20B
Total Liabilities$7.48B
Current Liabilities$3.86B
Total Debt$2.04B
Short Term Debt$82.80M
Accounts Payable$461.70M

Expenses

VRTX Expenses
MetricValueDate
Total Expenses$8.05B
Operating Expenses$5.68B
Cost Of Goods Sold$1.81B
SG&A$0.00
D&A$209.80M
Interest Expense$0.00
Income Tax$690.00M

Cash Flow

VRTX Cash Flow
MetricValueDate
CFO$3.63B
CFI-$945.40M
CFF-$2.26B
Capex$437.60M
Free Cash Flow$3.19B

Recent analyst updates

VRTX Recent analyst updates
MetricValueDate
Truist Securities→
Barclays→
TD Cowen→
Cantor Fitzgerald→
Canaccord Genuity→
UBS→
Truist Securities→
RBC Capital→
Baird→
Barclays→

Analyst sentiment

Sentiment over the past month
VRTX analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
VRTX institutional ownership distribution chart

Screeners with VRTX

FAQ

What is the ticker symbol for Vertex Pharmaceuticals Incorporated?
The ticker symbol for Vertex Pharmaceuticals Incorporated is NASDAQ:VRTX
Does Vertex Pharmaceuticals Incorporated pay dividends?
No, Vertex Pharmaceuticals Incorporated does not pay dividends
What sector is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Healthcare sector
What industry is Vertex Pharmaceuticals Incorporated in?
Vertex Pharmaceuticals Incorporated is in the Biotechnology industry
What country is Vertex Pharmaceuticals Incorporated based in?
Vertex Pharmaceuticals Incorporated is headquartered in United States
When did Vertex Pharmaceuticals Incorporated go public?
Vertex Pharmaceuticals Incorporated initial public offering (IPO) was on July 24, 1991
Is Vertex Pharmaceuticals Incorporated in the S&P 500?
Yes, Vertex Pharmaceuticals Incorporated is included in the S&P 500 index
Is Vertex Pharmaceuticals Incorporated in the NASDAQ 100?
Yes, Vertex Pharmaceuticals Incorporated is included in the NASDAQ 100 index
Is Vertex Pharmaceuticals Incorporated in the Dow Jones?
No, Vertex Pharmaceuticals Incorporated is not included in the Dow Jones index
When was Vertex Pharmaceuticals Incorporated last earnings report?
Vertex Pharmaceuticals Incorporated's most recent earnings report was on August 3, 2026
When does Vertex Pharmaceuticals Incorporated report earnings?
The next expected earnings date for Vertex Pharmaceuticals Incorporated is November 2, 2026

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  3. List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
  4. List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
  5. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  6. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx